Big Buttons

• FDA doubles down: Tirzepatide is off shortage

  ...but that doesn't mean the issue is completely settled. read more →

• A couple of state updates

  Good news from Alabama, but a problem in Massachusetts read more →

• Defending GLP-1 compounding

  The latest letters APC's been sending to oppose efforts to restrict compounding read more →

• Thumbs-up for FDA crackdown

  APC was thrilled when the FDA announced it was taking action against illegal online businesses claiming to sell “research-grade” compounds. read more →

• A PANS/PANDAS explainer

  For your patients: Information about a couple of underdiagnosed pediatric mental health conditions read more →

• What, a year?

  In the final board chair column of the year, here are our top 7 accomplishments in 2024. read more →

• “Simply not a rational approach to regulating an industry”

  This week APC offered its final (and pointed) suggestions to the California Board of Pharmacy on their proposed significant – and we would say unjustified – changes to their compounding regulations. read more →

• Get a cease and desist letter from Verrica?

  APC has heard reports from several pharmacies that have received them — here's what to know. read more →

More News

Yesterday, more than 8,000 pharmacy compounders were sent – via email – APC’s 2023 Compounder Profile Survey. Please take time to complete it.

Developed with our research partners at the University of Utah School of Pharmacy, the results of this survey will provide some clarity on the state of the compounding profession — how it’s structured, what compounders are doing in their businesses, and yes, what are the challenges you’re facing.

Your responses to the survey will be aggregated to produce APC’s “Snapshot of Pharmacy Compounding in America 2023,” which will support APC’s advocacy work – especially in helping members of Congress and other policy makers better understand your profession. 

Note: The survey comes to you in the form of an email from University of Utah College of Pharmacy. The actual email address is surveys@qualtrics-research.com. Be sure to check your spam folder if you don’t receive it soon.